Genome pioneer Craig Venter dies at 79

Craig Venter, a key figure in sequencing the human genome and advancing synthetic biology, has died at age 79. The J. Craig Venter Institute announced his death followed a brief hospitalization for side effects from cancer treatment. Venter leaves a legacy of breakthroughs and controversies in genomics.

Craig Venter, founder of the J. Craig Venter Institute, died following a brief hospitalization for unexpected side effects from treatment of recently diagnosed cancer, the institute said. He was 79. Venter played a leading role in sequencing the human genome and later pioneered work in synthetic biology, driving both major advances and debates over commercializing research and treating science as a race. His path to prominence began after serving as a war orderly in Vietnam, which motivated him to pursue biomedical research at the National Institutes of Health in the 1980s. There, he pioneered automated sequencing of expressed sequence tags, sparking early controversy when he sought to patent them despite unknown functions. In 1998, frustrated by the pace of the publicly funded Human Genome Project launched in 1990, Venter founded Celera. His team employed shotgun sequencing—shattering DNA into random fragments for computer reassembly—contrasting the HGP's methodical Sanger approach. Both efforts announced draft human genome sequences in 2000, with publications following in 2001, though Celera initially withheld some data for commercialization. Post-genome, Venter's yacht Sorcerer II collected global seawater samples from 2004 to 2006, revealing millions of proteins and over 1,000 new families. In 2010, his team created a synthetic cell by inserting a lab-made genome into Mycoplasma capricolum, replacing its original from Mycoplasma mycoides. The cell thrived, marking a milestone in synthetic life, though critics questioned its practical value. Venter later worked on minimal genomes, uncovering many essential genes of unknown function. His enormous impact on genomics, biology, and biodiversity will shape scientific history.

Related Articles

Illustration of the BBVA Foundation awards ceremony recognizing scientific advances in cryptography, ocean studies, and cancer therapies.
Image generated by AI

BBVA Foundation Frontiers of Knowledge Awards Recognize Advances in Cryptography, Oceans and Cancer Therapies

Reported by AI Image generated by AI

The XVIII edition of the BBVA Foundation Frontiers of Knowledge Awards took place yesterday in Bilbao, honoring ten individuals and two institutions for their contributions across scientific fields.

Bootstrap Bio and Manhattan Genomics, biotech firms launched last year to pursue human embryo editing for preventing serious diseases, have closed their doors. The companies cited financial difficulties and internal conflicts as reasons for the shutdowns. The developments highlight challenges in the controversial field of gene-edited babies.

Reported by AI

Mark Zuckerberg is supporting a $500 million effort to develop AI models of human cells. The funding targets Biohub's Virtual Biology Initiative, aimed at curing diseases through vast biological data analysis. The project forms part of a long-term health research push.

Dan Simmons, known for his science fiction works including the novel Hyperion, passed away on February 21, 2026, at the age of 77. He had previously worked as an educator in Colorado for nearly three decades.

Reported by AI

A US company plans to offer an unapproved gene therapy designed to boost levels of an anti-ageing protein called klotho. The treatment will be provided at clinics in Honduras, the Bahamas and Panama. It aims to bypass US regulatory requirements.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline